Fragility index analysis for robustness of evidence in randomized controlled trials leading to the US Food and Drug Administration approval of pharmacological therapies for endometriosis

This study analyzed the fragility index of randomized controlled trials supporting FDA-approved endometriosis pharmacotherapies to assess the robustness of their supporting evidence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works